AbbVie updates 2026 EPS guidance after $291M IPR&D charge

Go back to AbbVie updates 2026 EPS guidance after $291M IPR&D charge
AbbVie (NYSE: ABBV) Delayed: 259.36 +2.44 (0.95%)
Previous Close $256.92    52 Week High $68.12 
Open $258.54    52 Week Low $50.71 
Day High $260.22    P/E 56.26 
Day Low $256.77    EPS $4.61 
Volume 4,195,205